BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32619726)

  • 1. Elevated platelet lymphocyte ratio is a poor prognostic factor in advanced epithelial ovarian cancer.
    Chon S; Lee S; Jeong D; Lim S; Lee K; Shin J
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101849. PubMed ID: 32619726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis.
    Ceran MU; Tasdemir U; Colak E; Güngör T
    J Ovarian Res; 2019 Feb; 12(1):16. PubMed ID: 30744662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Preoperative Platelet to Lymphocyte Ratio Indicates Poor Survival in Patients with Resected High-grade Serous Ovarian Carcinoma.
    Hu D; Lin Y; Liu F; Zeng L; Ouyang X; Wang K; Zheng X; Huang Q
    Clin Lab; 2016 Aug; 62(8):1443-1449. PubMed ID: 28164624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 6. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis.
    Ma XM; Sun X; Yang GW; Yu MW; Zhang GL; Yu J; Zhang Y; Wang XM
    Climacteric; 2017 Oct; 20(5):448-455. PubMed ID: 28569074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer.
    Yildiz Y; Kucukzeybek Y; Alacacioglu A; Varol U; Yildiz I; Akyol M; Kabadayι G; Taskaynatan H; Salman T; Bayoglu V; Oflazoglu U; Tarhan MO
    Eur J Gynaecol Oncol; 2017; 38(3):444-448. PubMed ID: 29693888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of elevated pretreatment serum levels of CEA and CA-125 in epithelial ovarian cancer.
    Lin YH; Wu CH; Fu HC; Chen YJ; Chen YY; Ou YC; Lin H
    Cancer Biomark; 2020; 28(3):285-292. PubMed ID: 32390605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
    Zhang Y; Jiang C; Li J; Sun J; Qu X
    Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.
    Luo Y; Kim HS; Kim M; Lee M; Song YS
    J Gynecol Oncol; 2017 May; 28(3):e36. PubMed ID: 28382799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Thurner EM; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Br J Cancer; 2014 May; 110(10):2524-30. PubMed ID: 24675383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
    Tian C; Song W; Tian X; Sun Y
    Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer.
    Li Y; Zhang C; Ji R; Lu H; Zhang W; Li LL; Liu R; Qian H; He A
    Int J Gynecol Cancer; 2020 Jan; 30(1):74-82. PubMed ID: 31822507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
    Komura N; Mabuchi S; Yokoi E; Shimura K; Kawano M; Matsumoto Y; Kimura T
    Int J Gynecol Cancer; 2019 Jul; 29(6):1057-1063. PubMed ID: 31203199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.
    Zhang WW; Liu KJ; Hu GL; Liang WJ
    Tumour Biol; 2015 Nov; 36(11):8831-7. PubMed ID: 26063409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.
    Komura N; Mabuchi S; Yokoi E; Kozasa K; Kuroda H; Sasano T; Matsumoto Y; Kimura T
    Int J Clin Oncol; 2018 Feb; 23(1):104-113. PubMed ID: 28951992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma.
    Li Z; Yin H; Ren M; Shen Y
    Med Sci Monit; 2020 Sep; 26():e925051. PubMed ID: 32908118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.